Cogent Biosciences, Inc.
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -33.7% | -33.7% | -31.1% |
| FY2022 | -54.8% | -54.8% | -46.6% |
| FY2023 | -74.6% | -74.6% | -61.4% |
| FY2024 | -99.8% | -99.8% | -78.0% |
| FY2025 | -51.7% | -38.3% | -35.1% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2021 | -33.7% | -33.7% | -31.1% |
| FY2022 | -54.8% | -54.8% | -46.6% |
| FY2023 | -74.6% | -74.6% | -61.4% |
| FY2024 | -99.8% | -99.8% | -78.0% |
| FY2025 | -51.7% | -38.3% | -35.1% |